de novo design in the synthetically accessible compounds universe

webinar

Tue, 23 Feb 2016, 16:00 CET (Berlin)

Dr. Christian Lemmen, BioSolveIT GmbH, St. Augustin, Germany

de novo design in the synthetically accessible compounds universe

No matter how big your in-house library and no matter how many compounds you acquire as supplement, it merely scratches the surface of what chemists are capable of synthesizing. Recent publications indicate that the majority of chemical space is defined on the basis of only 50-70 robust chemical reactions. We have used these to compile a Chemical Space comprising billions of virtual compounds with high likelihood of straight forward synthetic access. We make this literature-derived collection publicly available and also provide a unique similarity search method capable to explore such wealth of data. Imagine de novo design of (a) hit expansion libraries, (b) follow-up series and (c) fragment evolution designs from within an all accessible compound space. We will demonstrate how this can become reality.

Current news

category
Events
AI/ML in Early Drug Discovery: From Data to Decisions (Hybrid Colloquium)
January 21, 2026 11:40 CET
We invite biotech/pharma investors, VCs, computational chemists, and medicinal chemists. Join Congruence Therapeutics for a focused industry colloquium exploring practical AI/ML workflows in early small molecule drug discovery. This event brings together experts to discuss how AI/ML is being applied in real discovery programs today, separating real impact from platform...
Read on
Tool of the Month - SpaceLight
January 19, 2026 13:46 CET
Spotlight on SpaceLight: Navigating Billions Efficiently In the search for the next lead candidate, medicinal chemists must balance structural similarity with the requirement for synthetic accessibility. This month, we spotlight SpaceLight, our algorithm designed to navigate the “beyond-billion” scale of Chemical Spaces with high accuracy.   What Does SpaceLight Do?...
Read on
category
Events
BioSolveIT at 34th GP2A 2026 Conference on Medicinal Chemistry in Gothenburg
December 17, 2025 15:19 CET
BioSolveIT is honored and excited to participate in the 34th GP2A 2026 Conference on Medicinal Chemistry in Gothenburg. From August 26 to 28, 2026, the Group for the Promotion of Pharmaceutical Chemistry in Academia (GP2A), a member-led network of academic medicinal chemists working at universities and research institutes in Europe,...
Read on